STIMULATION OF ER+ BREAST-CANCER CELLS PRIOR TO ADMINISTRATION OF CELL-CYCLE-SPECIFIC CHEMOTHERAPY

被引：0
|
作者：
KIMLER, BF
FABIAN, C
PARK, CH
机构：
[1] UNIV KANSAS,MED CTR,DEPT RADIAT THERAPY,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
来源：
CELL AND TISSUE KINETICS | 1983年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [31] ER−/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection
    Wei Ying
    Sumeng Wang
    Junfeng Shi
    Yujie Sun
    Medical Oncology, 2012, 29 : 495 - 502
  • [32] Estimating the cost of adjuvant chemotherapy in ER+/HER2-early breast cancer and distant recurrence of breast cancer in the UK
    Berdunov, V.
    Millen, S.
    Paramore, A.
    Reynia, S.
    Fryer, N.
    Griffin, J.
    Georges, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S46 - S46
  • [33] TUMOR PLOIDY AND CLINICAL OUTCOME IN PATIENTS WITH ER+ ADVANCED BREAST-CANCER TREATED BY HORMONE-THERAPY
    PARADISO, A
    BARLETTA, A
    MANGIA, A
    TOMMASI, S
    SIMONE, G
    DELENA, M
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 178 - 178
  • [34] DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle
    Dees, C
    Askari, M
    Foster, JS
    Ahamed, S
    Wimalasena, J
    MOLECULAR CARCINOGENESIS, 1997, 18 (02) : 107 - 114
  • [35] PRIMARY COMBINATION CHEMOTHERAPY PRIOR TO SURGERY OR RADIOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER
    LESNICK, G
    PERLOFF, M
    KORZUN, A
    CHU, F
    NORTON, L
    HOLLAND, JF
    CANCER DRUG DELIVERY, 1986, 3 (01): : 54 - 54
  • [36] BREAST-CANCER - CHEMOTHERAPY PRIOR TO LOCOREGIONAL TREATMENT WITH WIDER USE OF CONSERVATIVE THERAPY
    JACQUILLAT, C
    BAILLET, F
    AUCLERC, G
    BLONDON, J
    FACCHINI, T
    AUCLERC, MF
    MARAL, J
    KHAYAT, D
    WEIL, M
    SEMAINE DES HOPITAUX, 1985, 61 (20): : 1452 - 1456
  • [37] Color-coded selective chemotherapy of methioninase-synchronized S-phase cancer cells expressing cell-cycle-specific fluorescent reporters: A general approach to the treatment of cancer
    Yano, Shuya
    Li, Shukuan
    Han, Qinghong
    Tan, Yuying
    Fujiwara, Toshiyoshi
    Hoffman, Robert M.
    CANCER RESEARCH, 2012, 72
  • [38] The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
    Romain Tropée
    Bárbara de la Peña Avalos
    Madeline Gough
    Cameron Snell
    Pascal H. G. Duijf
    Eloïse Dray
    Breast Cancer Research and Treatment, 2021, 185 : 601 - 614
  • [39] EFFECTS OF MEDROXYPROGESTERONE ACETATE (MPA) ON CELL-CYCLE KINETICS OF BREAST-CANCER CELLS
    SUTHERLAND, RL
    ANTICANCER RESEARCH, 1986, 6 (03) : 367 - 367
  • [40] PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells
    Miranda E. Clements
    Rachelle W. Johnson
    Oncogene, 2020, 39 : 1318 - 1334
12345